Stock listing
NASDAQ:MDCX Medicus Pharma Ltd. Stock
Home listing (NASDAQ) of Medicus Pharma Ltd.
Follow Medicus Pharma Ltd. into a list and get an email when it puts out news.
Share price · NASDAQ:MDCX
$1.14 USD -0.25 (-18.3%)
Close on Nov 20, 2026
- Day range
- $1.06 – $1.23 USDNov 20, 2026
- Volume
- 86,765 sharesNov 20, 2026
- Market cap
- $2.18M USDAt the close on Nov 20, 2026 · price × 1.92M shares outstanding
- 52-week range
- $1.06 – $114.00 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $88,363 USDMedian day 7,266 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:MDCX · Home | $1.135 USD | -0.255 (-18.3%) | 86,765 | $1.13 | $1.23 | $1.06 | $1.39 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:MDCX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.135 | -0.255 | -18.3% | $1.13 | $1.23 | $1.06 | 86,765 | |
| $1.39 | -0.13 | -8.6% | $1.52 | $1.52 | $1.35 | 54,902 | |
| $1.52 | -0.17 | -10.1% | $1.69 | $1.815 | $1.50 | 64,186 | |
| $1.69 | -0.26 | -13.3% | $1.98 | $2.017 | $1.65 | 77,935 | |
| $1.95 | +0.23 | +13.4% | $1.75 | $2.00 | $1.70 | 47,990 | |
| $1.72 | +0.08 | +4.9% | $1.68 | $1.74 | $1.65 | 37,673 | |
| $1.64 | -0.19 | -10.4% | $1.80 | $1.853 | $1.63 | 53,476 | |
| $1.83 | -0.055 | -2.9% | $1.92 | $2.10 | $1.72 | 87,456 | |
| $1.885 | +0.015 | +0.8% | $1.87 | $2.165 | $1.789 | 61,905 | |
| $1.87 | +0.04 | +2.2% | $1.88 | $2.00 | $1.81 | 29,304 | |
| $1.83 | -0.05 | -2.7% | $1.85 | $1.906 | $1.70 | 42,584 | |
| $1.88 | -0.15 | -7.4% | $2.12 | $2.156 | $1.71 | 233,987 | |
| $2.03 | +0.10 | +5.2% | $1.95 | $2.12 | $1.90 | 25,977 | |
| $1.93 | +0.05 | +2.7% | $1.86 | $1.982 | $1.78 | 30,806 | |
| $1.88 | -0.27 | -12.6% | $2.17 | $2.18 | $1.82 | 86,634 | |
| $2.15 | -0.33 | -13.3% | $2.48 | $2.48 | $2.125 | 123,204 | |
| $2.48 | +0.03 | +1.2% | $2.50 | $2.689 | $2.45 | 19,908 | |
| $2.45 | -0.06 | -2.4% | $2.50 | $2.623 | $2.40 | 43,239 | |
| $2.51 | +0.01 | +0.4% | $2.53 | $2.63 | $2.41 | 38,542 | |
| $2.50 | -0.12 | -4.6% | $2.60 | $2.61 | $2.50 | 83,983 | |
| $2.62 | -0.06 | -2.2% | $2.70 | $2.80 | $2.57 | 44,155 | |
| $2.68 | -0.04 | -1.5% | $2.71 | $2.907 | $2.65 | 30,707 | |
| $2.72 | +0.065 | +2.4% | $2.60 | $2.93 | $2.56 | 92,115 | |
| $2.655 | -0.595 | -18.3% | $3.12 | $3.233 | $2.55 | 99,356 | |
| $3.25 | -0.18 | -5.2% | $3.61 | $3.61 | $3.25 | 28,223 | |
| $3.43 | +0.31 | +9.9% | $3.09 | $3.653 | $3.00 | 203,135 | |
| $3.12 | -0.16 | -4.9% | $3.08 | $3.25 | $2.921 | 69,943 | |
| $3.28 | -0.30 | -8.4% | $3.54 | $3.675 | $3.14 | 66,106 | |
| $3.58 | -1.025 | -22.3% | $4.20 | $4.69 | $3.58 | 125,038 | |
| $4.605 | -0.49 | -9.6% | $4.325 | $4.74 | $4.20 | 6,933 | |
| $5.095 | -2.915 | -36.4% | $5.75 | $5.775 | $4.705 | 5,824 | |
| $8.01 | +0.05 | +0.6% | $8.00 | $8.15 | $7.995 | 1,915 | |
| $7.96 | -0.39 | -4.7% | $8.27 | $8.47 | $7.90 | 422 | |
| $8.35 | +0.30 | +3.7% | $8.275 | $8.545 | $7.755 | 685 | |
| $8.05 | +0.20 | +2.5% | $7.80 | $8.19 | $7.75 | 416 | |
| $7.85 | -0.20 | -2.5% | $7.91 | $8.095 | $7.665 | 453 | |
| $8.05 | +0.22 | +2.8% | $7.875 | $8.42 | $7.75 | 726 | |
| $7.83 | +0.225 | +3.0% | $7.55 | $7.945 | $7.50 | 563 | |
| $7.605 | -0.015 | -0.2% | $7.545 | $7.775 | $7.35 | 609 | |
| $7.62 | -0.32 | -4.0% | $8.01 | $8.02 | $7.505 | 840 | |
| $7.94 | -0.03 | -0.4% | $8.25 | $8.25 | $7.725 | 1,098 | |
| $7.97 | -0.23 | -2.8% | $8.00 | $8.15 | $7.755 | 600 | |
| $8.20 | -0.35 | -4.1% | $8.40 | $8.50 | $7.85 | 1,471 | |
| $8.55 | +0.035 | +0.4% | $8.50 | $8.795 | $8.315 | 1,178 | |
| $8.515 | -0.015 | -0.2% | $8.46 | $8.775 | $7.90 | 1,206 | |
| $8.53 | +0.72 | +9.2% | $7.90 | $9.35 | $7.90 | 7,811 | |
| $7.81 | +0.205 | +2.7% | $7.505 | $7.99 | $7.505 | 1,324 | |
| $7.605 | -0.36 | -4.5% | $7.55 | $7.78 | $7.375 | 1,267 | |
| $7.965 | -0.165 | -2.0% | $8.34 | $8.35 | $7.20 | 2,187 | |
| $8.13 | +0.06 | +0.7% | $7.84 | $8.13 | $7.675 | 1,435 | |
| $8.07 | -0.45 | -5.3% | $8.59 | $8.62 | $7.85 | 7,266 | |
| $8.52 | +0.02 | +0.2% | $8.18 | $8.59 | $8.18 | 1,975 | |
| $8.50 | -0.10 | -1.2% | $8.60 | $10.13 | $8.055 | 9,358 | |
| $8.60 | +0.075 | +0.9% | $8.11 | $9.15 | $8.00 | 6,347 | |
| $8.525 | -4.47 | -34.4% | $10.25 | $10.33 | $7.56 | 38,664 | |
| $13.00 | +0.435 | +3.5% | $12.58 | $13.00 | $12.58 | 142 | |
| $12.56 | -0.53 | -4.0% | $13.00 | $13.08 | $12.50 | 192 | |
| $13.09 | +0.205 | +1.6% | $12.75 | $13.28 | $12.63 | 167 | |
| $12.89 | -0.505 | -3.8% | $13.31 | $13.56 | $12.77 | 236 | |
| $13.39 | -0.035 | -0.3% | $13.48 | $13.75 | $13.10 | 281 | |
| $13.43 | +0.375 | +2.9% | $13.54 | $13.54 | $12.77 | 294 | |
| $13.05 | +0.18 | +1.4% | $12.68 | $13.75 | $12.68 | 344 | |
| $12.87 | -0.72 | -5.3% | $13.50 | $13.75 | $12.75 | 330 | |
| $13.59 | -0.02 | -0.1% | $13.32 | $13.75 | $13.26 | 341 | |
| $13.61 | +0.385 | +2.9% | $13.50 | $14.00 | $13.04 | 961 |
Splits
2 splits since 2024 · NASDAQ:MDCX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-50 | Consolidation | |
| 1-for-2 | Consolidation |
- Ticker
- NASDAQ:MDCX
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Medicus Pharma Regains Compliance with Nasdaq Minimum Equity Requirement for Continued Listing
Latest earnings call · Nov 9, 2026
Medicus Pharma (NASDAQ:MDCX) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 9, 2026
Q3 2026 Earnings Presentation
Earnings · 30 slides
Calls
Replays
Medicus Pharma (NASDAQ:MDCX) Q3 2026 Earnings Call
Mon, Nov 09, 2026 · 11:30 AM ET
Watch Transcript
Latest news
Medicus Pharma Regains Compliance with Nasdaq Minimum Equity Requirement for Continued Listing
Nov 19, 2026
Closed $1.14 (-18.3%) on Nov 20, 2026
Medicus Pharma Announces Closing of $4.25 Million CEO-Led Equity Financings and $10.5 Million Debt Exchange
Nov 16, 2026
Closed $1.69 (-13.3%) on Nov 16, 2026
Medicus Pharma to Highlight Rationale for CD228V Co-Development and License Agreement
Nov 9, 2026
Closed $1.89 (+0.8%) on Nov 9, 2026
Medicus Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Nov 6, 2026
Closed $1.89 (+0.8%) on Nov 9, 2026
Medicus Pharma to Present at BIO-Europe 2026
Nov 5, 2026
Closed $1.83 (-2.7%) on Nov 5, 2026
Medicus Pharma to Host Third Quarter 2026 Financial Performance and Business Update Call on November 9, 2026
Nov 4, 2026
Closed $1.83 (-2.7%) on Nov 5, 2026
Medicus Pharma Announces Proposed SkinJect® Business Combination and Concurrent Financing
Nov 4, 2026
Closed $1.88 (-7.4%) on Nov 4, 2026
Medicus Pharma to Present at BioFuture and Global Biotechnology Summit
Oct 27, 2026
Closed $2.45 (-2.4%) on Oct 27, 2026
Medicus Pharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
Oct 26, 2026
Closed $2.51 (+0.4%) on Oct 26, 2026
Medicus Pharma Highlights Three Years of Progress and Outlines Potential Path to Long Term Value
Oct 8, 2026
Closed $5.10 (-36.4%) on Oct 8, 2026
Financings
Private placement of common shares
Nov 16, 2026
Closed: US$1.25M raised · US$1.72 a share
Buyers: Dr. Raza Bokhari (through RBx Capital LP) (436,046 common shares; $750,000)
Insiders: Certain directors and senior officers purchased an aggregate of 616,272 common shares, including $750,000 from the Executive Chairman and CEO
Use of proceeds: Working capital for operating and development priorities including CD228V, and possibly debt repayment
Registered direct offering of common shares and pre-funded warrants
Nov 16, 2026
Closed: US$3M raised · US$1.72 a share · Maxim Group LLC
Dealers: Maxim Group LLC
Use of proceeds: Working capital for operating and development priorities including CD228V, and possibly debt repayment
At-the-market programme of common shares
Nov 16, 2026
Tranche closed: US$350,000 raised
Warrant exercise of series A and Series B Warrants exercised for common shares
Dec 5, 2025
Announced: about US$5.1M · US$1.92 a share · ½ warrant at US$2 for 66 months · Maxim Group LLC
Dealers: Maxim Group LLC
Non-dilutive debenture
Sep 18, 2025
Closed: US$8M raised
Buyers: YA II PL, Ltd. (Yorkville) (purchased the $8.0 million principal amount debenture)
Use of proceeds: Accelerate development of Teverelix for acute urinary retention and high CV risk prostate cancer
Common shares
Feb 11, 2025
Announced: raise
Buyers: YA II PN, LTD (option to sell up to US$15,000,000 of common shares over 36 months)
Decks
Q3 2026 Earnings Presentation
Earnings · 30 slides · Nov 9, 2026
Medicus Pharma Ltd. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 55 in the last 12 months · 89 in all · newest Nov 19, 2026 · oldest 2024
- Calls
- 1 call with a replay · 1 with a transcript · latest Nov 9, 2026
- Decks
- 1 deck · latest Nov 9, 2026
Where Medicus Pharma Ltd. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:MDCX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:MDCX | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Medicus Pharma Ltd.